Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice

Neuropharmacology

Volumn 61, Issue 8, 2011, Pages 1229-1238

  Cravezic, Aurore ^a   Fichna, Jakub ^b   Gach, Katarzyna ^b   Wyrebska, Anna ^b   Perlikowska, Renata ^b   Costentin, Jean ^a   Bonnet, Jean Jacques ^a   Janecka, Anna ^b   Do Rego, Jean Claude ^a,c  

^a UNIVERSITÉ DE ROUEN   (France)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c CNRS   (France)

Author keywords

Opioid receptors; Analgesic effect; Antidepressant like effect; Endomorphin 1; Endomorphin 2; Enzymatic hydrolysis

Indexed keywords

DELTA OPIATE RECEPTOR; ENDOMORPHIN 1; ENDOMORPHIN 2; ENDORPHIN DERIVATIVE; MU OPIATE RECEPTOR; TETRAPEPTIDE; TRIPEPTIDE; TYROSYLALANYL DEXTRO PHENYLALANYLALANYLAMIDE; TYROSYLALANYLALANYLAMIDE; TYROSYLALANYLALANYLPHENYLALANYLAMIDE; TYROSYLALANYLPHENYLALANYLPHENYLALANYLAMIDE; TYROSYLGLYCYLALANYLAMIDE; TYROSYLGLYCYLALANYLPHENYLALANYLAMIDE; TYROSYLPROLYL DEXTRO PHENYLALANYLALANYLAMIDE; TYROSYLPROLYLALANYLAMIDE; TYROSYLPROLYLALANYLPHENYLALANYLAMIDE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT LIKE EFFECT; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENZYME INHIBITION; FORCED SWIMMING TEST; HOT PLATE TEST; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSION; DIPEPTIDYL PEPTIDASE 4; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HYPERALGESIA; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOTOR ACTIVITY; OLIGOPEPTIDES; PAIN MEASUREMENT; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SWIMMING; TRITIUM;

EID: 80053597731     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.07.021     Document Type: Article

References (54)

1. A. Asakawa, A. Inui, K. Momose, N. Ueno, M.A. Fujino, and M. Kasuga Endomorphins have orexigenic and anxiolytic activities in mice NeuroReport 9 1998 2265 2267 (Pubitemid 28338218)
2. Z. Bagosi, M. Jaszberenyi, E. Bujdoso, G. Szabo, and G. Telegdy The effects of endomorphins and diprotin A on striatal dopamine release induced by electrical stimulation-an in vitro superfusion study in rats Neurochem Int. 49 2006 665 668 (Pubitemid 44572568)
3. A. Bedini, M. Baiula, L. Gentilucci, A. Tolomelli, R. De Marco, and S. Spampinato Peripheral antinociceptive effects of the cyclic endomorphin 1 analog c[YPWFG] in a mouse visceral pain model Peptides 31 2010 2135 2140
4. R.J. Bodnar Endogenous opiates and behavior: 2009 Peptides 31 2010 2325 2359
5. H.C. Champion, J.E. Zadina, A.J. Kastin, L. Hackler, L.J. Ge, and P.J. Kadowitz Endomorphin 1 and 2, endogenous ligands for the μ-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat Peptides 18 1997 1393 1397 (Pubitemid 27519751)
6. H.C. Champion, T.J. Bivalacqua, D.G. Lambert, S.M. McWilliams, J.E. Zadina, A.J. Kastin, and P.J. Kadowitz Endomorphin 1 and 2, the endogenous μ-opioid agonists, produce biphasic changes in systemic arterial pressure in the cat Life Sci. 63 1998 PL131 PL136
7. M.A. Czapla, H.C. Champion, J.E. Zadina, A.J. Kastin, L. Hackler, L.J. Ge, and P.J. Kadowitz Endomorphin 1 and 2, endogenous μ-opioid agonists, decrease systemic arterial pressure in the rat Life Sci. 62 1998 PL175 PL179
8. M.A. Czapla, D. Gozal, O.A. Alea, R.C. Beckerman, and J.E. Zadina Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine Am. J. Respir. Crit. Care Med. 162 2000 994 999
9. N. Doi, C.H. Brown, H.D. Cohen, G. Leng, and J.A. Russell Effects of the endogenous opioid peptide, endomorphin-1, on supraoptic nucleus oxytocin and vasopressin neurons in vivo and in vitro Br. J. Pharmacol. 132 2001 1136 1144 (Pubitemid 32238919)
10. J.C. do Rego, C. Suaudeau, G. Chapouthier, and J. Costentin Mouse lines differing in sensitivity to beta-CCM differ in tasks used for testing antidepressants Pharmacol. Biochem. Behav. 72 2002 411 416 (Pubitemid 34251352)
11. J.C. do Rego, D. Chatenet, M.H. Orta, B. Naudin, C. Le Cudennec, J. Leprince, E. Scalbert, H. Vaudry, and J. Costentin Behavioural effects of urotensin-II centrally administered in mice Psychopharmacology (Berl.) 183 2005 103 117 (Pubitemid 41484187)
12. J.C. do Rego, M.H. Orta, J. Leprince, M.C. Tonon, H. Vaudry, and J. Costentin Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake Neuropsychopharmacology 32 2007 1641 1648 (Pubitemid 46920157)
13. N.B. Eddy, and D. Leimbach Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines J. Pharmacol. Exp. Ther. 107 1953 385 393
14. J. Fichna, J.C. do Rego, P. Kosson, J. Costentin, and A. Janecka Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third position Biochem. Pharmacol. 69 2005 179 185 (Pubitemid 39592884)
15. J. Fichna, A. Janecka, L. Bailly, F. Marsais, J. Costentin, and J.C. do Rego In vitro characterisation of novel peptide inhibitors of endomorphin-degrading enzymes in the rat brain Chem. Biol. Drug Des 68 2006 173 175 (Pubitemid 44630334)
16. J. Fichna, A. Janecka, J. Costentin, and J.C. do Rego The endomorphin system and its evolving neurophysiological role Pharmacol. Rev. 59 2007 88 123 (Pubitemid 46333997)
17. J. Fichna, A. Janecka, M. Piestrzeniewicz, J. Costentin, and J.C. do Rego Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice Neuropsychopharmacology 32 2007 813 821 (Pubitemid 46426170)
18. 2 (EMDB-2) prolong endomorphin-2 action in rat ileum in vitro Chem. Biol. Drug Des. 76 2010 77 81
19. L. Hackler, J.E. Zadina, L.J. Ge, and A.J. Kastin Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex Peptides 18 1997 1635 1639 (Pubitemid 28133009)
20. 2-adrenoceptors in the rat tail flick, tail pressure and formalin tests Life Sci. 66 2000 PL195 PL204
21. G. Horvath, M. Szikszay, C. Tomboly, and G. Benedek Antinociceptive effects of intrathecal endomorphin-1 and -2 in rats Life Sci. 65 1999 2635 2641
22. A. Janecka, J. Fichna, R. Kruszynski, Y. Sasaki, A. Ambo, J. Costentin, and J.C. do Rego Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs Biochem. Pharmacol. 71 2005 188 195 (Pubitemid 41713540)
23. A. Janecka, R. Kruszynski, J. Fichna, P. Kosson, and T. Janecki Enzymatic degradation studies of endomorphin-2 and its analogs containing N-methylated amino-acids Peptides 27 2006 131 135 (Pubitemid 43061046)
24. A. Janecka, R. Staniszewska, K. Gach, and J. Fichna Enzymatic degradation of endomorphins Peptides 29 2008 2066 2073
25. A. Lehmann Atlas stéréotaxique du cerveau de la souris 1974 Edition du Centre National de la Recherche Scientifique Paris
26. R. Mentlein Dipeptidyl peptidase IV (CD26) - role in the inactivation of regulatory peptides Regul. Pept. 85 1999 9 24 (Pubitemid 29505281)
27. H. Nishiwaki, N. Saitoh, H. Nishio, T. Takeushi, and F. Hata Inhibitory effect of endomorphin-1 and -2 on acetylcholine release from myenteric plexus of guinea pig ileum Jpn. J. Pharmacol. 78 1998 83 86 (Pubitemid 28464218)
28. R. Perlikowska, K. Gach, J. Fichna, G. Toth, B. Walkowiak, J.C. do Rego, and A. Janecka Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2 Bioorg. Med. Chem. 17 2009 3789 3794
29. Perlikowska, R., Fichna, J., do Rego, J.C., Gach, K., Janecka, A. Kinetic studies of novel inhibitors of endomorphin degrading enzymes. Med. Chem. Res., in press, doi:10.1007/s00044-011-9666-5.
30. A. Péter, G. Toth, C. Tomboly, G. Laus, and D. Tourwe Liquid chromatographic study of the enzymatic degradation of endomorphins, with identification by electrospray ionization mass spectrometry J. Chromatogr. A. 846 1999 39 48 (Pubitemid 29332622)
31. B. Petit-Demouliere, F. Chenu, and M. Bourin Forced swimming test in mice: a review of antidepressant activity Psychopharmacology (Berl.) 177 2005 245 255 (Pubitemid 40137284)
32. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch. Int. Pharmacodyn. Ther. 229 1977 327 336 (Pubitemid 8225714)
33. B. Przewlocka, J. Mika, D. Labuz, G. Toth, and R. Przewlocki Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats Eur. J. Pharmacol. 367 1999 189 196 (Pubitemid 29106370)
34. S. Sakurada, J.E. Zadina, A.J. Kastin, S. Katsuyama, T. Fujimura, K. Murayama, M. Yuki, H. Ueda, and T. Sakurada Differential involvement of μ-opioid receptor subtypes in endomorphin-1 and -2-induced antinociception Eur. J. Pharmacol. 372 1999 25 30 (Pubitemid 29229860)
35. S. Sakurada, T. Hayashi, M. Yuhki, T. Orito, J.E. Zadina, A.J. Kastin, T. Fujimura, K. Murayama, C. Sakurada, T. Sakurada, M. Narina, T. Suzuki, K. Tan-no, and L.F. Tseng Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse Eur. J. Pharmacol. 427 2001 203 210 (Pubitemid 32913287)
36. C. Sakurada, S. Sakurada, T. Hayashi, S. Katsuyama, K. Tan-No, and T. Sakurada Degradation of endomorphin-2 at the supraspinal level in mice is initiated by dipeptidyl peptidase IV: an in vitro and in vivo study Biochem. Pharmacol. 66 2003 653 661 (Pubitemid 37281284)
37. E. Schon, I. Born, H.U. Demuth, J. Faust, K. Neubert, T. Steinmetzer, A. Barth, and S. Ansorge Dipeptidyl peptides IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes Biol. Chem. Hoppe. Seyler 372 1991 305 311
38. J.I. Semba, and R. Takahashi Effect of monoamine precursors on the forced-swimming test in mice Psychopharmacology (Berl.) 95 1988 222 225
39. R. Shane, S. Wilk, and R.J. Bodnar Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV Brain. Res. 815 1999 278 286 (Pubitemid 29231321)
40. M. Spetea, K. Monory, C. Tomboly, G. Toth, E. Tzavara, S. Benyhe, J. Hanoune, and A. Borsodi In vitro binding and signaling profile of the novel μ opioid receptor agonist endomorphin 2 in rat brain membranes Biochem. Biophys. Res. Commun. 250 1998 720 725 (Pubitemid 28484794)
41. L.S. Stone, C.A. Fairbanks, T.M. Laughlin, H.O. Nguyen, T.M. Bushy, M.W. Wessendorf, and G.L. Wilcox Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2 NeuroReport 8 1997 3131 3135 (Pubitemid 27421745)
42. M. Storr, E. Gaffal, V. Schusdziarra, and H.D. Allecher Endomorphins 1 and 2 reduce relaxant non-adrenergic, non-cholinergic neurotransmission in rat gastric fundus Life Sci. 71 2002 383 389 (Pubitemid 34607303)
43. M. Storr, A. Hahn, E. Gaffal, D. Saur, and H.D. Allesher Effects of endomorphin-1 and -2 on μ-opioid receptors in myenteric neurons and in the peristaltic reflex in rat small intestine Clin. Exp. Pharmacol. Physiol. 29 2002 428 434 (Pubitemid 34535365)
44. R.H. Straub, C. Wolff, A. Fassold, R. Hofbauer, A. Chover-Gonzalez, L.J. Richards, and D.S. Jessop Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis Arthritis Rheumat. 58 2008 456 466 (Pubitemid 351294880)
45. A. Sugimoto-Watanabe, K. Kubota, K. Fujibayashi, and K. Saito Antinociceptive effect and enzymatic degradation of endomorphin-1 in newborn rat spinal cord Jpn. J. Pharmacol. 81 1999 264 270
46. R. Sunal, B. Gumusel, and S.O. Kayaalp Effect of changes in swimming area on results of "behavioral despair test" Pharmacol. Biochem. Behav. 49 1994 891 896
47. R. Tao, and S.B. Auerbach Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system J. Pharmacol. Exp. Ther. 303 2002 549 556 (Pubitemid 35231225)
48. C. Tomboly, A. Peter, and G. Toth In vitro quantitative study of the degradation of endomorphins Peptides 23 2002 1573 1580 (Pubitemid 35246276)
49. C. Tomboly, K.E. Kover, A. Peter, D. Tourwe, D. Biyashev, S. Benyhe, A. Borsodi, M. Al-Khrasani, A.Z. Ronai, and G. Toth Structure-activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues J. Med. Chem. 47 2004 735 743 (Pubitemid 38129731)
50. M. Tonini, E. Fiori, B. Balestra, V. Spelta, G. D'Agostino, A. Di Nucci, N.C. Brecha, and C. Sternini Endomorphin-1 and endomorphin-2 activate μ-opioid receptors in myenteric neurons of the guinea-pig small intestine Naunyn-Schmiedeberg's Arch. Pharmacol. 358 1998 686 689 (Pubitemid 28563774)
51. T. Yamaguchi, K. Kitagawa, and Y. Kuraishi Itch-associated response and antinociception induced by intracisternal endomorphins in mice Jpn. J. Pharmacol. 78 1998 337 343 (Pubitemid 28554201)
52. J.E. Zadina, L. Hackler, L.J. Ge, and A.J. Kastin A potent and selective endogenous agonist for the mu-opiate receptor Nature (Lond.) 386 1997 499 502 (Pubitemid 27164076)
53. J.E. Zadina Isolation and distribution of endomorphins in the central nervous system Jpn. J. Pharmacol. 89 2002 203 208
54. H. Zhang, M.M. Torregrossa, E.M. Jutkiewicz, Y.G. Shi, K.C. Rice, J.H. Woods, S.J. Watson, and M.C. Ko Endogenous opioid upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects Eur. J. Neurosci. 23 2006 984 994 (Pubitemid 43344693)